The expression of genes from genomic loci can be relatively complex, utilizing exonic, intronic and flanking sequences to regulate tissue and developmental specificity. Infectious bacterial artificial chromosomes (iBACs) have been shown to deliver and express large genomic loci (up to 135 kb) into primary cells for functional analyses. The delivery of large genomic DNA inserts allows the expression of complex loci and of multiple splice variants. Herein, we demonstrate for the first time that an iBAC will deliver and correctly express in human glioma cells the entire CDKN2A/CDKN2B genomic region, which encodes for at least three important cell-cycle regulatory proteins (p16
Introduction
The complexity of gene expression includes alternative splicing mechanisms, 1 alternative promoter-enhancer usage, 2 intronic gene expression, 3 expression of inhibiting RNAs, 4 and effects of DNA polymorphisms. 5 Such mechanisms likely account for the large diversity of proteins (greater than 100 000 per cell) derived from a relatively small number of human genes (around 30 000) and for their expression with tissue and developmental specificity. [6] [7] [8] Despite the increasing appreciation of the subtle complexities of gene expression, most current gene therapy viral vector systems employ cDNA or 'minigene' constructs that cannot easily recapitulate the context of a genomic locus.
The delivery of a gene as a genomic locus would allow gene expression to be controlled by the native promoter and regulated by the endogenous enhancer and silencer elements in the correct genomic locus context. However, expression of large foreign genomic sequences in cells and/or animals remains inefficient with current methods of transfection/electroporation. The packaging constraints of most viral vectors limit the size of foreign DNA to a maximum of 30 kilobases (kb), 9 a value that is less than the size of the average human genomic locus (see http:/ /www.ensembl.org/Homo_sapiens/martview).
In this respect, we have recently developed the infectious bacterial artificial chromosome (iBAC) method that allows for the efficient delivery into primary cells of genomic loci up to B150 kb, a size that should permit expression of 95% of all human genes from their genomic loci (http:/ /www.ensembl.org/Homo_sapiens/martview). The iBAC takes advantage of the packaging capacity of herpes simplex virus type 1 (approximately 150-160 kb) 10, 11 and of recent advances in packaging of foreign DNA into the virus in a 'gutless' manner without helper virus contamination. 12 Genomic sequences delivered into cells by the iBAC persist as extrachromosomal elements. 10, 11 As such, they can be easily recovered and reanalyzed and/or re-engineered in bacteria, thus allowing for potentially exquisite experimental manipulations. As proof-of-principle of the iBAC technology, we have previously shown that the genomic locus for human hypoxanthine phosphoribosyltransferase (HPRT) contained within a 115 kb BAC insert could be efficiently expressed in primary cells. 10 We have further shown that transfer and expression of the human low-density lipoprotein receptor (LDLR) gene contained within a 135 kb BAC insert resulted in the expected and correct regulation of the LDLR gene promoter by sterols in primary human fibroblasts taken from familial hypercholesterolemia (FH) patients. 11 This result thus showed that iBAC-delivered genes retained physiological regulation of gene expression, even in their extrachromosomal environment.
Further validation of the iBAC method to recapitulate genome complexity requires demonstration of the retention of alternative splicing and differential promoter usage. The chromosomal region 9p21.3 spanning the CDKN2A and CDKN2B loci demonstrates complex splicing and alternative promoter usage by overlapping genes. 2, 13 The region contains only six exons. Nevertheless, it encodes five proteins involved in cell-cycle control. The major three proteins are p16
INK4a
, p14 ARF and p15
INK4b
. The CDKN2A locus generates two distinct important proteins, p16
INK4a and p14
ARF
, from different promoters, both of which function in the cell cycle to regulate proliferation and apoptosis. 14 The generation of these two proteins from this locus is relatively complex. There are two alternative first exons, 1a for p16
INK4a and 1b for p14 ARF . Each of these two first exons is spliced to common second and third exons to make two functionally different proteins with no amino-acid homology to one another. The p16
INK4a protein binds and inhibits Cdk4 and Cdk6, which phosphorylate the retinoblastoma protein (pRB), an event that results in G1 arrest. 13 In contrast, p14
ARF interacts directly with Mdm2 to stabilize and activate p53 to induce growth arrest and apoptosis. 15, 16 There is also an additional splice variant of p16 INK4a , termed p12, produced specifically in the pancreas, in a tissue-specific manner. 17 Finally, an alternative form of p15
INK4b , termed p10, is known. 18, 19 The 9p21.3 deletion has been reported to be one of the most frequent mutations found in cancer and in human glioblastomas (GBMs) in particular. [20] [21] [22] [23] [24] In fact, animal models have shown that the combined loss of INK4a and ARF from neural stem cells or astrocytes predisposes to GBM formation. 25, 26 Therefore, the genomic manipulations permitted by the iBAC methodology could provide an avenue for further study of this interesting locus and the development of novel therapeutic strategies.
To show that the CDKN2A/CDKN2B genomic region is correctly spliced and retains its functionality when delivered as a transgene, we have generated iBAC-CDKN2 vectors. We report that glioma cells, originally deleted for the CDKN2A/CDKN2B locus, show expression of p16
INK4a , p14 ARF and p15 INK4b after infection with iBAC-CDKN2. Functionally, this results in an apoptotic or growth-arrest response, dependent on cellular p53 status. Therefore, alternative splicing and promoter usage mechanisms are retained within the context of iBAC expression.
Results

Construction of iBAC-CDKN2 vectors
The combined CDKN2A and CDKN2B region on chromosome 9p21.3 contains some of the most complex splicing seen in the human genome. 2 The region contains six exons encoding five proteins by differential promoter usage and alternative splicing, the best characterized being p16
INK4a
, p14 ARF and p15 INK4b ( Figure 1a ). We first 
INK4b
( Figure 1b) . The HSV-1 amplicon-based iBAC system has been shown to have a total packaging capacity of approximately 150-160 kb. 10, 11 To modify the CDKN2 insert to fit within this packaging capacity, we used EcoRI RecAassisted restriction endonuclease (RARE) cleavage 27 to remove 63 kb of extreme flanking DNA 3 0 of the CDKN2A locus (Figure 1c) . We then confirmed the precise nature of the RARE manipulation by PCR analysis of the newly formed junctions (Figure 1d) .
The modified CDKN2 BAC clone carrying an insert of 132 kb was then retrofitted with HSV-1 amplicon elements using a Cre/loxP-based method. [10] [11] [12] The methodology exploits the presence of a single wild-type loxP site in all BAC library clones. First, retrofitting the modified 132 kb CDKN2 BAC with pHG (carrying the ori s and pac elements from HSV-1) created pHSV-CDKN2, a 148 kb HSV-1 amplicon. Second, retrofitting with pEHHG (containing the episomal retention elements from Epstein-Barr virus (EBV) in addition to the ori s and pac sequences) created pHSV/EBV-CDKN2, a 154 kb HSV-1/EBV hybrid amplicon. Lastly, we reconfirmed the presence of all the p16
INK4a , p14 ARF and p15 INK4b exons in the final pHSV-CDKN2 and pHSV/EBV-CDKN2 constructs (not shown).
Characterization of the CDKN2A/CDKN2B region within human glioma cells
We wished to identify null cell lines lacking the CDKN2A/CDKN2B region to use as model systems to test the functional consequence of physiological levels of gene expression from our iBAC-CDKN2 vectors. To identify cell lines carrying homozygous deletions of the CDKN2A/CDKN2B region, we tested 10 glioma cell lines from the Massachusetts General Hospital Brain Tumor Bank for the presence or absence of p16
INK4a , p14 ARF and p15 INK4b by screening for the presence of each exon by PCR. Four of the 10 glioma cell lines showed a complete absence of all six exons and presumably carry a homozygous deletion of the entire region ( Figure 2a ). We selected Gli-33 and Gli-36 for further study as an example of a primary and immortalized glioma line, respectively. We designed primer pairs to detect specifically expression of each spliced gene and confirmed that the Gli-33 and Gli-36 cell lines do not express any of the CDKN2 mRNAs, as expected ( Figure 2b ).
In addition, we also chose to work with the U87 glioma-immortalized cell line, which is known to have a complete deletion of the CDKN2 genomic region, 28 and confirmed that U87 cells do not express any of the CDKN2A or CDKN2B mRNAs (not shown). The U87 glioma line was, however, relatively resistant to HSV-1 amplicon infection. To overcome this, we used a retroviral construct expressing the herpesvirus entry protein C (HveC) 29 to create a highly infectable HveC þ -U87 derivative cell line, hereafter referred to simply as U87 (see Materials and methods for details).
Intact packaging and infectious delivery of the 132 kb CDKN2A/CDKN2B region
We packaged the pHSV-CDKN2 and pHSV/EBV-CDKN2 amplicons in Vero 2-2 cells using an improved helper virus-free HSV-1 amplicon packaging system, 12 as described previously. 10, 11 Amplicon titers were measured as green fluorescent protein (GFP)-transducing units on Infectious delivery of the CDKN2A/CDKN2B locus R Inoue et al G16-9 cells, a derivative of the human glioma cell line Gli-36 (see Materials and methods). Amplicon titers of B2-3 Â 10 7 transducing units per milliliter (t.u./ml) were routinely obtained after concentration. pHG and pEHHG were also packaged and used as vector-only control amplicons in CDKN2A and CDKN2B expression analysis.
To demonstrate intact infectious delivery of the 132 kb CDKN2A/CDKN2B genomic region by both pHSV-CDKN2 and pHSV/EBV-CDKN2, we infected the human glioma cell line U87 with each amplicon. At 48 h after infection, total genomic DNA was prepared from the infected cells and a small aliquot was used to transform DH-10B Escherichia coli cells by electroporation. The HSV-1 amplicon DNA is linear inside the virion, but recircularizes upon entry into the nucleus. The plasmid rescue assay shuttles recircularizes BAC plasmid from the infected U87 cells back into the bacterial host. After selection of transformed bacteria on chloramphenicol/ ampicillin plates, we prepared plasmid DNA from surviving colonies. The plasmid DNA was digested by NotI, analyzed by pulsed-field gel electrophoresis and compared to the original starting DNA preparation used for packaging (Figure 3a and b) . The 148 kb pHSV-CDKN2 and the 154 kb pHSV/EBV-CDKN2 were both found to be delivered to and rescued intact from U87 cells with 80% efficiency. This high level of intact delivery mediated by the iBAC system is in-line with previous reports. 10, 11 iBAC-CDKN2 infectious delivery leads to correctly spliced gene expression
We then infected glioma cell lines null for the CDKN2A/ CDKN2B region with the pHSV-CDKN2 and pHSV/EBV-CDKN2 vectors to assay gene expression and function. Levels of infection efficiency of B50% were readily obtained with a multiplicity of infection (MOI) of 3. Using RT-PCR primers carefully designed to differentiate between expressions of each gene, we then assayed the infected cells for expression of p16 INK4a , p14 ARF and p15
INK4b (Figure 4 ). Each of the three genes was correctly expressed and spliced after delivery with each iBAC-CDKN2 vector. Moreover, the RT-PCR results indicate the levels of p16
INK4a , p14 ARF and p15 INK4b expression were approximately equal to those of normal human fibroblasts, when the efficiency of vector delivery (B50%) is taken into account. This confirms that iBACmediated delivery of CDKN2 resulted in broadly physiological levels of re-expression of these three genes in glioma cells that were previously deleted for this genomic region, consistent with our previous expression data for BAC-based vectors. 10, 11, 30 Glioma cell growth inhibition following iBAC-CDKN2 infectious delivery
Following the demonstration of correct expression of the three known cell-cycle inhibition genes from the CDKN2A/CDKN2B loci, we examined the effect of iBAC-CDKN2 gene expression on tumor cell growth in vitro. The immortalized tumor cell lines Gli-36 and U87 were infected with the pHSV-CDKN2 and pHSV/EBV-CDKN2 vectors and the control pHG and pEHHG amplicons at the same MOI. Cell growth was then followed using the WST growth assay over 3 days for Gli-36 and 5 days for U87. Glioma cells infected with the pHG or pEHHG control amplicons showed no difference in growth from uninfected cells, whereas cells infected with pHSV-CDKN2 or pHSV/EBV-CDKN2 showed significant inhibition of cell growth by day 3 (Po0.01 by Student's t-test; Figure 5a and b) . We then extended this result to a primary tumor line by performing a pHSV/ EBV-CDKN2 infection of the Gli-33 cells that resulted in Figure 3 pHSV-CDKN2 and pHSV/EBV-CDKN2 transfer an intact 132 kb genomic DNA insert by infectious delivery in U87 glioma cells. Plasmid rescue of (a) pHSV-CDKN2 and (b) pHSV/EBV-CDKN2 demonstrates intact delivery of both vectors at an efficiency of 80%. Plasmid DNA was prepared from bacterial colonies from each rescue assay, digested with NotI and analyzed by PFGE. Plasmids (16/20 and 8/10) rescued represent intact pHSV-CDKN2 and pHSV/EBV-CDKN2, respectively.
Infectious delivery of the CDKN2A/CDKN2B locus R Inoue et al significant growth repression by day 5, again not seen in a control pEHHG infection (Figure 5c ).
Analysis of apoptosis in glioma cells infected with iBAC-CDKN2 amplicons
To understand further the mechanisms leading to the inhibition of cell proliferation following infectious delivery of the iBAC-CDKN2 vectors, we assayed the p53 status of the immortalized tumor lines Gli-36 and U87 in our cultures. Gli-36 and U87 cells were cotransfected with a plasmid containing the firefly luciferase reporter gene controlled by a p53-responsive element and a plasmid expressing the renilla luciferase reporter gene driven by the thymidine kinase promoter. Cotransfection of the two plasmids into the human osteosarcoma cell line, Saos2, which is known to have both p53 alleles deleted, 31 served as a negative control. The ratios of firefly to renilla luciferase expression for Gli-36, U87 and Saos2 were 0.318, 27.76 and 0.149, respectively. The data confirmed previous reports that U87 cells express functional p53 32 and indicated that Gli-36 cells do not express functional p53 protein.
We therefore used iBAC-CDKN2 infection of the Gli-36 and U87 lines to compare the mechanisms of growth repression of p53-negative and p53 wild-type cells in response to the combined expression of physiologically relevant levels p16
INK4a , p14 ARF and p15 INK4b . We looked for evidence of apoptosis in infected glioma cells. Gli-36 and U87 cells were infected with iBAC-CDKN2 vectors or empty control amplicons at an MOI of 10 and cellular morphology was observed following infection. At 3 days postinfection, U87 cells infected with CDKN2 amplicon were sparse, aggregated and rounded up, suggestive of cells undergoing apoptosis, whereas cells infected with empty amplicons grew rapidly and showed no Infectious delivery of the CDKN2A/CDKN2B locus R Inoue et al morphological changes (Figure 6a ). Furthermore, we performed TUNEL analysis 2 days following infection. A high proportion of U87 cells infected with iBAC-CDKN2 amplicons showed positive TUNEL staining indicating cells undergoing apoptosis, whereas U87 cells infected with control amplicons showed negative TUNEL staining (Figure 6b ). In contrast Gli-36 cells infected with iBAC-CDKN2 did not produce positive TUNEL staining (not shown), as expected from their absence of functional p53.
Flow cytometric analysis of cell-cycle progression of infected cells stained with Hoechst 23342 also demonstrated apoptosis in U87 cells (Figure 7 ). The traces in Figure 7a clearly show an increased number of U87 cells in the pre-G1 (sub-G0) phase following infection with pHSV-CDKN2 and pHSV/EBV-CDKN2 as compared to pHG and pEHHG at 48 and 72 h postinfection. The data are represented graphically in Figure 7b and show the increase of cells in the pre-G1 phase to be highly significant by Student's t-test (Po0.01). Again, flow cytometric analysis of Gli-36 did not show an increase in the number of cells in the pre-G1 phase, but showed evidence for G1 arrest (not shown), as expected from their absence of functional p53. Taken together, these 
Discussion
Recent reports have clearly demonstrated the advantages gained in gene expression utilizing a genomic DNA locus over cDNA-based expression cassettes. These advantages include prolonged vector retention and gene expression, 10, 30, 33, 34 correct native promoter regulation, 11 and, now, the expression of multiple splice variants from the delivery of one locus. In this report, for the first time, we have demonstrated that iBAC-mediated gene delivery and expression leads to functionally correct complex splicing and promoter usage of 132 kb of CDKN2A/ CDKN2B genomic locus. The work further demonstrates the ability of the iBAC system to deliver a genomic locus that functions like an endogenous chromosomal region. There has been no previous report on the delivery of the entire CDKN2A/CDKN2B genomic locus and its effects on tumor suppression. Data presented in this paper are the first demonstration of multiple genes exhibiting complex splicing being expressed simultaneously from a large genomic DNA insert following infectious delivery. The correction of genetic abnormalities in Infectious delivery of the CDKN2A/CDKN2B locus R Inoue et al human neoplasm is an interesting strategy to cure or to control cell growth. Human gliomas, especially glioblastomas, are one of the most difficult tumors in human to treat effectively because of their location within the brain and invasiveness into brain parenchyma. Such tumors remain untreatable despite a combination of surgery, radiation and chemotherapy. [35] [36] [37] Recent genetic analyses of human gliomas have identified them as a disease caused by the accumulation of genetic mutations, including deletions or amplifications, in genes related to cell-cycle regulation. 38, 39 Among the many genes involved in pathways of cell-cycle regulation, p16
ARF are well known to play a critical role in cellcycle progression. 13 These two genes are encoded from a complex region of chromosome 9p21.3 and are transcribed from overlapping reading frames.
A number of studies have been recently published describing the antitumor effects of expressing p16
INK4a
and p14
ARF in tumor cells. [40] [41] [42] [43] [44] [45] These reports describe overexpression of tumor suppressor genes by viral transfer of the cDNA of interest. Such studies find that the cellular response to overexpression of p16
INK4a and p14 ARF depends on the p53 status of cells. 42, 44 There have been no studies that have addressed the cellular response to re-expression of p16
INK4a or p14 ARF at physiological levels, nor to the simultaneous re-expression of p16
ARF and p15 INK4b . Restoration of expression of physiological levels of tumor suppressor genes may have distinct advantages compared to overexpression, as overexpression of p16 may induce aberrant differentiation processes. 43, 46 Using the iBAC system, the level of expression of each of the three genes (p16 INK4a , p14 ARF and p15 INK4b ) occurs from a genomic locus, under the control of the native promoters, and at approximately physiologically relevant levels when the number of infected cells is considered (see Figure 4 , where iBAC expression is compared to fibroblast expression). We use the term 'physiological' to refer to expression levels obtained from our vectors using endogenous promoters, which are broadly equivalent to levels seen in wild-type cells. This contrasts with the high levels of gene overexpression seen from convectional vectors in which a cDNA is expressed from a strong, heterologous viral promoter. The data in this paper confirms previous work in which we have shown quantitative analysis of gene expression from genomic loci carried by BAC-based vectors. We recently showed physiological expression levels and transcriptional regulation of the human LDLR gene from an iBAC-LDLR vector in primary human cells. 11 Previous to that, we showed physiological expression levels of the HPRT gene from each copy of a BAC vector using two different assay measurements. 10, 30 Taken together, these data demonstrate physiologically appropriate expression levels from genomic loci carried by our BAC-based expression vectors.
We were interested to compare the functional effect of physiological levels of the expression of the tumor suppressor genes with the reported results from overexpression studies. The genetic status of the glioma cells was important in determining the cellular response to the vector-derived CDKN2A/CDKN2B locus expression. We find that only glioma cells expressing p53 wild-type protein, such as U87 cells, were able to undergo apoptosis as assayed by flow cytometry and TUNEL analysis. In contrast, p53-mutant Gli-36 cells underwent growth arrest after infectious delivery of CDKN2 genomic region without a significant increase in apoptosis. In the Gli-36 cells, thus, expression of p14 ARF in the absence of functional p53 did not result in a apoptotic response. These findings are in agreement with the overexpression studies, 42, 44 and thus confirm the general mechanism of cell response to recorrection of p16
INK4a , p14 ARF and p15 INK4b expression and, importantly for our objectives, validate the iBAC's ability to provide phenotypically correct gene expression even in the context of a locus with complex splicing and promoter usage mechanisms.
The work provides a basis for future studies of gene expression from this genomic region. First, the vector system will be used to investigate potential therapeutic applications of simultaneous expression of the three cell-cycle control genes under physiological control, and second the system is well suited to assess the importance of polymorphisms, methylation events, and chromatin acetylation in the maintenance of this region in tumors. 47 Finally, we have previously shown that episomal BAC vectors are highly stable in long-term cell cultures and are retained in dividing cells at B96-98% efficiency. 30, 48 This makes the system suitable for functional genomics expression studies requiring long-term maintenance of unrearranged exogenous genomic loci.
Materials and methods
Vector construction
The fully sequenced BAC 149I2 clone (Genbank AL449423) from the RCPI-11 library was identified as containing the complete CDKN2A/CDKN2B region by screening publicly available databases (http://www. ncbi.nlm.gov) and was obtained from Research Genetics (Huntsville, AL, USA). EcoRI RARE cleavage was used as described previously 27 to remove 63 kb of flanking sequence 3 0 to the CDKN2A locus by using 60-mer oligos (5 0 -agcaagtgtattcaataGAATTCaattgaattctattctataattcaattg ttcttaatt-3 0 and 5 0 -ctaatatgtaagtca-ttttcttttccaGAATTC ctgctcttccagttttcactatctggg-3 0 ; EcoRI site shown in capitals). The retrofitting vector pHG contains the HSV-1 amplicon elements (ori s and pac) and the GFP reporter gene from pHSV-GFP (a gift from C Fraefel), the R6Kg bacterial replication origin from pSG76-A (a gift from G Posfai) and a loxP site. pEHHG contains in addition the EBV episomal retention cassette (oriP/ EBNA-1/hyg r ) from pH300 (a gift from J-M Vos). The retrofitting protocol used Cre-mediated recombination in bacterial cells and was performed as described previously. 10, 12 Characterization of CDKN2A/CDKN2B null cell lines PCR of genomic DNA was used to amplify each exon in the CDKN2A/CDKN2B region using the following primers pairs, listed as (forward primer; reverse primer): p14 exon 1b (5 0 -GAGGCG-GCGAGAACATGGTG-3 Tissue culture MRC-5V2 (an SV40-immortalized human male lung fibroblast cell line), Gli-33, Gli-36 and U87 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), penicillin (100 U/ml) and streptomycin (100 mg/ ml) (P/S). HveC þ U87 cells were derived by infection with the pBABEHveCpuro (VSV pseudotyped) retrovirus and selection of puromycin-resistant cell populations as described previously.
11
Vero 2-2 cells (a derivative of Vero African green monkey kidney cells constitutively expressing the HSV-1 ICP27 protein) were grown in DMEM, 10% FBS, P/S and G418 (Geneticin; LifeTechnologies, Rockville, MD, USA) at 500 mg/ml. G16-9 cells (a derivative of the human Gli-36 glioma cell line expressing the HSV-1 VP-16 protein to enhance expression from the amplicon pIE4/5-GFP promoter cassette (Y Saeki and EA Chiocca, unpublished materials)) were cultured in DMEM, supplemented with 10% FBS, P/S and hygromycin-B (200 mg/ml). All cells were cultured at 371C in 5% (v/v) CO 2 .
HSV-1 amplicon production
HSV-1 amplicons were produced using an improved HSV-1 helper virus-free system as described previously. [10] [11] [12] Typically, the supernatant from nine 6 cm dishes was concentrated by ultracentrifugation and resuspended in 500 ml Hank's balanced salt solution to give a stock of 2 Â 10 7 transducing units/ml when titered for GFP expression on a confluent G16-9 cell layer.
Genomic analysis of infected cells
The plasmid rescue assays were performed as follows. 30, 48 For each rescue assay 1.5 Â 10 5 U87 cells were seeded into a 6 cm dish. After 1 day, the cells were infected with amplicon vectors pHSV-CDKN2 and pHSV/EBV-CDKN2 at an MOI of 3. After 48 h, genomic DNA was prepared from the infected cells and resuspended in 200 ml TE. DH-10B ElectroMax E. coli cells (Invitrogen, Carlsbad, CA, USA) were electroporated with 2 ml of genomic DNA extract and plated onto LB agar containing chloramphenicol (12.5 mg/ml) and ampicillin (100 mg/ml). Plasmid DNA was prepared from the resulting bacterial colonies, digested with NotI and the digests were resolved by pulsed field gel electrophoresis.
Amplicon infection and RT-PCR expression analysis
A total of 1 Â 10 5 (U87) or 2.5 Â 10 4 (Gli-36) cells were seeded per well of a 6-well plate. After 1 day, the cells were infected with amplicons at an MOI of 3 (U87) or 10 (Gli-36). At 48 h postinfection, total RNA was extracted from Gli-36 and U87 cells using Trizol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's protocol. RNA (5 mg) was reverse transcribed into cDNA by using First Strand Synthesis Kit (Invitrogen, Carlsbad, CA, USA) in a 20 ml reaction volume, of which 2 ml was then used for PCR amplification by AmpliTaq Gold DNA polymerase (Applied Biosystems, Foster City, CA, USA) using primers to detect specific transcripts from the CDKN2A/CDKN2B genomic region. The following primers pairs, listed as (forward primer; reverse primer), were used to detect specifically each transcript from the CDKN2A/CDKN2B region: p14 ARF 0 -GCCCATCATCATGACCTGG-3 0 ). As an RT-PCR internal control, we analyzed GAPDH expression using primers (5 0 -GGTCGGAGTCAACGGATTTGGTCG-3 0 ; 5 0 -CCTCCGACGCCTGCTTCACCAC-3 0 ).
Analysis of cell proliferation and apoptosis
For assays of cell growth and proliferation, the colorimetric WST-1-based assay was used. On day 0, 500 (Gli-36) or 1000 (Gli-33 and U87) cells were seeded per well into 96-well plate. On day 1, wells were infected with iBAC or control amplicons at MOI 20 (Gli-36) or 10 (Gli-33 and U87) in 200 ml of DMEM supplemented with 2% FBS and P/S. At various time points following infection, 10 ml of WST-1 Cell Proliferation Reagent (Roche, Indianapolis, IN, USA) was added to the cultures and the absorbance read at 450 nm by a microplate reader. Two methods were used to measure apoptotoic cell death. First, for TUNEL staining, U87 and Gli-36 cells were seeded in 4-well chamber slides, infected with iBAC or control amplicons at the same MOI as for the WST assays, fixed in 2% paraformaldehyde in PBS 2 days postinfection and subjected to TUNEL staining using the DeadEnd Colorimetric TUNEL assay (Promega, Madison, WI, USA). As a positive control for TUNEL staining, uninfected cells were treated with DNase I, according to the manufacturer's protocol. Flow cytometric analysis was used as a second measure of apoptosis. At 2 and 3 days postinfection, cells were stained with Hoechst 23342 dye solution (5 mg/ml in DMEM) for 45 min. The cells were then harvested by centrifugation at 1500 rpm for 10 min, washed once with PBS and finally fixed in 2% paraformaldehyde.
